124 related articles for article (PubMed ID: 2505151)
1. [Molecular analysis of mouse major histocompatibility complex class I gene expression of tumors growing in the brain].
Yamasaki T; Kikuchi H; Yamashita J; Kärre K; Ljunggren HG; Klein G
No Shinkei Geka; 1989 Mar; 17(3):229-37. PubMed ID: 2505151
[TBL] [Abstract][Full Text] [Related]
2. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
[TBL] [Abstract][Full Text] [Related]
3. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
Sibille C; Gould K; Hämmerling G; Townsend A
Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
[TBL] [Abstract][Full Text] [Related]
4. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
Yamasaki T; Kikuchi H; Yamashita J; Ljunggren HG; Karre K; Klein G
No Shinkei Geka; 1989 Aug; 17(8):717-23. PubMed ID: 2586713
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of expression of MHC class I and beta 2-microglobulin transcripts at early stages of mouse development.
Jaffe L; Robertson EJ; Bikoff EK
J Immunol; 1991 Oct; 147(8):2740-9. PubMed ID: 1918988
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
7. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines.
Klyczek KK; Murasko DM; Blank KJ
J Immunol; 1987 Oct; 139(8):2641-8. PubMed ID: 3116091
[TBL] [Abstract][Full Text] [Related]
9. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of H2 (class I) antigens and beta 2 microglobulin by interferon-gamma in interferon-sensitive and interferon-resistant Friend leukemia cells.
Coccia E; Marziali G; Fiorucci G; Romeo G; Affabris E; Battistini A; Rossi GB
J Biol Regul Homeost Agents; 1992; 6(1):21-5. PubMed ID: 1442172
[TBL] [Abstract][Full Text] [Related]
11. Regulation of TL antigen expression. Analysis of the T18d promoter region and responses to IFN-gamma.
Wang IM; Mehta V; Cook RG
J Immunol; 1993 Sep; 151(5):2646-57. PubMed ID: 8360484
[TBL] [Abstract][Full Text] [Related]
12. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.
Ladel CH; Flesch IE; Arnoldi J; Kaufmann SH
J Immunol; 1994 Oct; 153(7):3116-22. PubMed ID: 7726898
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system.
Njenga MK; Pease LR; Wettstein P; Mak T; Rodriguez M
Lab Invest; 1997 Jul; 77(1):71-84. PubMed ID: 9251680
[TBL] [Abstract][Full Text] [Related]
14. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
[TBL] [Abstract][Full Text] [Related]
16. Locus-specific regulation of Kd, Dd, and Ld class I genes in the BALB/c S49 lymphoma sublines.
Beck Keeney J; Hedayat M; Myers NM; Connolly JM; Hansen TH
J Immunol; 1989 Oct; 143(7):2364-73. PubMed ID: 2674281
[TBL] [Abstract][Full Text] [Related]
17. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of MHC class I and beta 2-microglobulin genes in vivo.
Drezen JM; Babinet C; Morello D
J Immunol; 1993 Apr; 150(7):2805-13. PubMed ID: 8454857
[TBL] [Abstract][Full Text] [Related]
19. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities.
Baerwald KD; Corbin JG; Popko B
J Neurosci Res; 2000 Jan; 59(2):160-9. PubMed ID: 10650874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
